Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04734847 · ClinicalTrials.gov registry record · NA

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

A NA study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04734847: Recruiting NA study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by University of Southern California.

NCT04734847 is a NA study of Interstitial Cystitis and Bladder Pain Syndrome that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 50 participants, below the 360-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04734847, a NA study of Interstitial Cystitis and Bladder Pain Syndrome, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a common, chronic, and debilitating condition in women. Preliminary evidence suggests that IC/BPS pain can be reduced applying non-invasive repetitive transcranial magnetic stimulation (rTMS) to areas of the brain that regulate pelvic floor muscle activity. However, prior studies have examined rTMS in a very limited sample and have not examined changes in brain or pelvic floor muscle activity to determine the mechanism of rTMS for IC/BPS. This study is designed to directly address these limitations.

Primary Outcome

Change in Visual Analog Scale of Pain. This scale ranges from 0 (no pain) to 10 (worst pain imaginable), so higher scores indicate more pain.

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)
  • DEVICE Sham Repetitive Transcranial Magnetic Stimulation (Sham-rTMS)

Study Locations (1)

California

  • University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-06-01
Est. Completion 2025-08-15
Phase NA
University of Southern California

617 total trials

What NCT04734847 shows while recruiting

NCT04734847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 360-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (86% lower).

The record links to 2 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.

NCT04734847 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04734847 about?

NCT04734847 is a clinical study titled "Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome". Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a common, chronic, and debilitating condition in women. Preliminary evidence suggests that IC/BPS pain can be reduced applying non-invasive repetitive transcranial magnetic stimulation (rTMS) to areas of the brain that regulate pelvic floor mus...

What is the current status of trial NCT04734847?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-06-01. Estimated completion is 2025-08-15.

What conditions does trial NCT04734847 study?

This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome.

What interventions are being tested in trial NCT04734847?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Sham Repetitive Transcranial Magnetic Stimulation (Sham-rTMS) (DEVICE).

Who is sponsoring clinical trial NCT04734847?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04734847 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Interstitial Cystitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04734847's enrollment target sits among peer trials

50 17th of 26 higher than 9 of 26 other Interstitial Cystitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04734847, the US trial registry maintained by the National Library of Medicine. NCT04734847 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.